Rèsa launches jewelry-grade AI bracelet built for women’s cycles

Women’s health brand Rèsa has launched its first product, a jewelry-grade wellness bracelet that turns hormonal, circadian, and stress signals into plain-language guidance. The bracelet debuts in the United States and is designed to give users cycle-aware insights without charts, scores, or paid access to core health data.

Why it matters: - Rèsa is aiming at a gap in mainstream wearables: most devices read women against a stable baseline, even though menstrual-cycle shifts can change what the same signal means. - The product is designed to help users make better decisions about work, recovery, and training based on their own rhythms. - The company is also taking a position on data access, saying core health insights should remain free.

What happened: - Women’s health brand Rèsa unveiled its first product: a jewelry-grade AI wellness bracelet. - The bracelet launches first in the United States. - Rèsa says the device reads three body rhythms — hormonal, circadian, and stress — and turns them into plain-language daily guidance. - Founder and CEO Jessie Du said women want explanation and decision support, not another dashboard of numbers.

The details: - The bracelet uses Rèsa’s Tri-Rhythm Engine to distinguish patterns tied to hormonal, circadian, and stress rhythms within the same physiological signals. - The device is designed to identify which rhythm is driving a user’s state and translate that into action-oriented guidance. - The app presents three layers of output: a plain-language read on current state, a forecast of energy peaks and dips, and guidance on when to push, recover, and adjust training. - Rèsa says the experience is meant to reduce “data anxiety” by lowering decision-making load. - The system builds a baseline unique to each user instead of comparing her with a population average. - Rèsa says the model becomes more accurate the longer the bracelet is worn. - Core health data and insights in the app will remain free. - Only AI-personalized lifestyle planning sits behind a premium tier. - The company says personal health data is not sold to advertisers or data brokers. - Users can request deletion of their personal data. - Rèsa says its data collection is limited to what is needed to deliver and improve the product.

Between the lines: - Rèsa is positioning itself against a common wearables model that treats the body as relatively stable from day to day. - The product’s cycle-aware approach could make readings feel more relevant for women whose biomarkers shift across the menstrual cycle. - That matters because the company says the same HRV reading can carry different meaning in the follicular versus luteal phase. - Rèsa does not measure blood or absolute hormone levels. - Instead, it infers hormonal trends and phases from surface signals including heart-rate variability, resting heart rate, skin temperature, sleep, respiration, and activity. - The company says peer-reviewed research supports the idea that these signals change alongside hormonal and cycle-related shifts. - Rèsa is validating its model outputs against urinary hormone measurements. - The brand is also leaning on premium positioning, with a gold-plated finish and real-jewelry design, to make the device feel more wearable all day.

What’s next: - Rèsa says it will continue validating inferred cycle patterns against independent hormone measurements. - The bracelet is built for continuous wear through work, workouts, sleep, and travel, which should improve the continuity of its data. - The company’s free-plus-premium model suggests future growth will depend on whether users find enough value in the personalized planning tier. - Rèsa is also relying on a co-creation community of 1,200 members across the US and China to shape the product.

The bottom line: - Rèsa is betting that women want cycle-aware guidance, not generic wellness metrics, and that privacy-first data practices can be part of the appeal.